BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shet AS, Lizarralde-Iragorri MA, Naik RP. The molecular basis for the prothrombotic state in sickle cell disease. Haematologica 2020;105:2368-79. [PMID: 33054077 DOI: 10.3324/haematol.2019.239350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kalff H, Cario H, Holzhauer S. Iron deficiency anemia and thrombosis risk in children—revisiting an old hypothesis. Front Pediatr 2022;10:926925. [DOI: 10.3389/fped.2022.926925] [Reference Citation Analysis]
2 Saade EA, Hojat LS, Gundelly P, Salata RA. Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders. Best Practice & Research Clinical Haematology 2022. [DOI: 10.1016/j.beha.2022.101375] [Reference Citation Analysis]
3 Wulftange WJ, Kucukal E, Man Y, An R, Monchamp K, Sevrain CD, Dashora HR, Owusu-Ansah AT, Bode A, Ilich A, Little JA, Key NS, Gurkan UA. Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow. Br J Haematol 2022. [PMID: 35822297 DOI: 10.1111/bjh.18328] [Reference Citation Analysis]
4 Torres LS, Asada N, Weiss MJ, Trumpp A, Suda T, Scadden DT, Ito K. Recent advances in "sickle and niche" research - Tribute to Dr. Paul S Frenette. Stem Cell Reports 2022;17:1509-35. [PMID: 35830837 DOI: 10.1016/j.stemcr.2022.06.004] [Reference Citation Analysis]
5 Singh A, Brandow AM, Wun T, Shet AS. COVID-19 and Venous Thromboembolism Risk in Patients With Sickle Cell Disease. Blood Adv 2022:bloodadvances. [PMID: 35763429 DOI: 10.1182/bloodadvances.2022007219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rankine-Mullings AE. Ulcerative colitis in patients with sickle cell disease: a rare but important co-morbidity. Paediatr Int Child Health 2022;:1-4. [PMID: 35694868 DOI: 10.1080/20469047.2022.2084964] [Reference Citation Analysis]
7 Ionescu F, Anusim N, Zimmer M, Jaiyesimi I. Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients. Eur J Haematol 2022. [PMID: 35617049 DOI: 10.1111/ejh.13807] [Reference Citation Analysis]
8 Notariale R, Perrone P, Mele L, Lettieri G, Piscopo M, Manna C. Olive Oil Phenols Prevent Mercury-Induced Phosphatidylserine Exposure and Morphological Changes in Human Erythrocytes Regardless of Their Different Scavenging Activity. Int J Mol Sci 2022;23:5693. [PMID: 35628502 DOI: 10.3390/ijms23105693] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Feugray G, Kasonga F, Grall M, Benhamou Y, Bobée-Schneider V, Buchonnet G, Daliphard S, Le Cam Duchez V, Lahary A, Billoir P. Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease. Front Med (Lausanne) 2022;9:858911. [PMID: 35492334 DOI: 10.3389/fmed.2022.858911] [Reference Citation Analysis]
10 Forté S, De Luna G, Abdulrehman J, Fadiga N, Pestrin O, Pham Hung d'Alexandry d'Orengiani AL, Aneke JC, Guillet H, Budhram D, Habibi A, Ward R, Bartolucci P, Kuo KHM. Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study. J Clin Med 2022;11:1193. [PMID: 35268283 DOI: 10.3390/jcm11051193] [Reference Citation Analysis]
11 Betensky M, Kumar R, Hankins JS, Goldenberg NA. Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.01.028] [Reference Citation Analysis]
12 Nader E, Garnier Y, Connes P, Romana M. Extracellular Vesicles in Sickle Cell Disease: Plasma Concentration, Blood Cell Types Origin Distribution and Biological Properties. Front Med (Lausanne) 2021;8:728693. [PMID: 34490315 DOI: 10.3389/fmed.2021.728693] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Sharathkumar AA, Faustino EVS, Takemoto CM. How we approach thrombosis risk in children with COVID-19 infection and MIS-C. Pediatr Blood Cancer 2021;68:e29049. [PMID: 33955167 DOI: 10.1002/pbc.29049] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
14 Conran N, Embury SH. Sickle cell vaso-occlusion: The dialectic between red cells and white cells. Exp Biol Med (Maywood) 2021;246:1458-72. [PMID: 33794696 DOI: 10.1177/15353702211005392] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Karki NR, Kutlar A. P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab. J Pain Res 2021;14:849-56. [PMID: 33833562 DOI: 10.2147/JPR.S278285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hopp MT, Imhof D. Linking Labile Heme with Thrombosis. J Clin Med 2021;10:427. [PMID: 33499296 DOI: 10.3390/jcm10030427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]